Senti Biosciences announces holding company reorganization, 1-for-1 share conversion by April 16

Filed April 1, 2026 · Period ending April 1, 2026 · ~1 min read

Key Changes

• high

  Shareholders will automatically receive one share of new parent company Senti Biosciences Holdings for each existing share, with identical rights and no action required. Stock continues trading on Nasdaq under ticker SNTI.

  Item 8.01 verify on EDGAR →
• medium

  Reorganization structured as tax-free transaction for U.S. federal income tax purposes, meaning shareholders will not recognize gains or losses on the automatic share conversion.

  Item 8.01 verify on EDGAR →
• medium

  Company may cancel or delay the reorganization beyond April 16, 2026 target date. Transaction does not require shareholder vote under Delaware law Section 251(g).

  Item 8.01 verify on EDGAR →